Open Access Helper

OpenAlex Citation Counts

OpenAlex Citations Logo

OpenAlex is a bibliographic catalogue of scientific papers, authors and institutions accessible in open access mode, named after the Library of Alexandria. It's citation coverage is excellent and I hope you will find utility in this listing of citing articles!

If you click the article title, you'll navigate to the article, as listed in CrossRef. If you click the Open Access links, you'll navigate to the "best Open Access location". Clicking the citation count will open this listing for that article. Lastly at the bottom of the page, you'll find basic pagination options.

Requested Article:

EPOS2020: A Major Step Forward
Wytske J. Fokkens
Rhinology Journal (2020) Vol. 58, Iss. 1, pp. 1-1
Open Access | Times Cited: 915

Showing 1-25 of 915 citing articles:

EUFOREA expert board meeting on uncontrolled severe chronic rhinosinusitis with nasal polyps (CRSwNP) and biologics: Definitions and management
Claus Bachert, J Han, Martin Wagenmann, et al.
Journal of Allergy and Clinical Immunology (2020) Vol. 147, Iss. 1, pp. 29-36
Open Access | Times Cited: 270
Adult chronic rhinosinusitis
Claus Bachert, Bradley F. Marple, Rodney J. Schlosser, et al.
Nature Reviews Disease Primers (2020) Vol. 6, Iss. 1
Closed Access | Times Cited: 234
Burden of Disease in Chronic Rhinosinusitis with Nasal Polyps
Claus Bachert, Neil Bhattacharyya, Martin Desrosiers, et al.
Journal of Asthma and Allergy (2021) Vol. Volume 14, pp. 127-134
Open Access | Times Cited: 174
Comparative efficacy and safety of monoclonal antibodies and aspirin desensitization for chronic rhinosinusitis with nasal polyposis: A systematic review and network meta-analysis
Paul Oykhman, Fernando Aleman Paramo, Jean Bousquet, et al.
Journal of Allergy and Clinical Immunology (2021) Vol. 149, Iss. 4, pp. 1286-1295
Open Access | Times Cited: 160
Mechanisms and pathogenesis of chronic rhinosinusitis
Atsushi Kato, Robert P. Schleimer, Benjamin S. Bleier
Journal of Allergy and Clinical Immunology (2022) Vol. 149, Iss. 5, pp. 1491-1503
Open Access | Times Cited: 152
Chronic Rhinosinusitis With Nasal Polyps: Quality of Life in the Biologics Era
Joaquim Mullol, Antoine Azar, Kathleen M. Buchheit, et al.
The Journal of Allergy and Clinical Immunology In Practice (2022) Vol. 10, Iss. 6, pp. 1434-1453.e9
Open Access | Times Cited: 91
Single-cell profiling identifies mechanisms of inflammatory heterogeneity in chronic rhinosinusitis
Weiqing Wang, Yi Xu, Lun Wang, et al.
Nature Immunology (2022) Vol. 23, Iss. 10, pp. 1484-1494
Closed Access | Times Cited: 87
Mepolizumab for chronic rhinosinusitis with nasal polyps: Treatment efficacy by comorbidity and blood eosinophil count
Claus Bachert, Ana R. Sousa, Joseph K. Han, et al.
Journal of Allergy and Clinical Immunology (2022) Vol. 149, Iss. 5, pp. 1711-1721.e6
Open Access | Times Cited: 80
International consensus statement on allergy and rhinology: Olfaction
Zara M. Patel, Eric H. Holbrook, Justin H. Turner, et al.
International Forum of Allergy & Rhinology (2022) Vol. 12, Iss. 4, pp. 327-680
Open Access | Times Cited: 78
The Anti-Inflammatory and Curative Exponent of Probiotics: A Comprehensive and Authentic Ingredient for the Sustained Functioning of Major Human Organs
Muhammad Safiullah Virk, Muhammad Abdulrehman Virk, Yufeng He, et al.
Nutrients (2024) Vol. 16, Iss. 4, pp. 546-546
Open Access | Times Cited: 44
The Relationship between Fine Particle Matter (PM2.5) Exposure and Upper Respiratory Tract Diseases
Łukasz Zaręba, Katarzyna Piszczatowska, Karolina Dżaman, et al.
Journal of Personalized Medicine (2024) Vol. 14, Iss. 1, pp. 98-98
Open Access | Times Cited: 16
Chronic Rhinosinusitis with Nasal Polyps and Biologics: A Call for Better Data Standardisation and Presentation in Clinical Studies
Harsha H. Kariyawasam, Dean Langan, Joanne Rimmer
Therapeutics and Clinical Risk Management (2025) Vol. Volume 21, pp. 27-34
Open Access | Times Cited: 2
Efficacy Assessment of Biological Treatments in Severe Asthma
Daniel Laorden, Javier Domínguez‐Ortega, David Romero, et al.
Journal of Clinical Medicine (2025) Vol. 14, Iss. 2, pp. 321-321
Open Access | Times Cited: 2
Tezepelumab in Adults with Severe Chronic Rhinosinusitis with Nasal Polyps
Brian J. Lipworth, Joseph K. Han, Martin Desrosiers, et al.
New England Journal of Medicine (2025)
Closed Access | Times Cited: 2
Shared genetic investigation of asthma and blood eosinophils in relation to chronic rhinosinusitis
Xian Li, Jingyun Li, Shibei Xue, et al.
Allergy Asthma and Clinical Immunology (2025) Vol. 21, Iss. 1
Open Access | Times Cited: 2
Eosinophil Knockout Humans: Uncovering the Role of Eosinophils Through Eosinophil-Directed Biological Therapies
Elizabeth A. Jacobsen, David J. Jackson, Enrico Heffler, et al.
Annual Review of Immunology (2021) Vol. 39, Iss. 1, pp. 719-757
Open Access | Times Cited: 100
Review of Rhinitis: Classification, Types, Pathophysiology
Georgia Liva, Alexander D. Karatzanis, Emmanuel P. Prokopakis
Journal of Clinical Medicine (2021) Vol. 10, Iss. 14, pp. 3183-3183
Open Access | Times Cited: 94
Chemosensory Dysfunction in COVID‐19: Prevalences, Recovery Rates, and Clinical Associations on a Large Brazilian Sample
Deusdedit Brandão Neto, Marco Aurélio Fornazieri, Caroline Dib, et al.
Otolaryngology (2020) Vol. 164, Iss. 3, pp. 512-518
Open Access | Times Cited: 88
Long-term efficacy and safety of omalizumab for nasal polyposis in an open-label extension study
Philippe Gevaert, Rebecca Saenz, Jonathan Corren, et al.
Journal of Allergy and Clinical Immunology (2021) Vol. 149, Iss. 3, pp. 957-965.e3
Open Access | Times Cited: 87
Systematic literature review of the epidemiology and clinical burden of chronic rhinosinusitis with nasal polyposis
Stephanie Chen, Anna Zhou, Benjamin Emmanuel, et al.
Current Medical Research and Opinion (2020) Vol. 36, Iss. 11, pp. 1897-1911
Open Access | Times Cited: 82
Adult‐onset eosinophilic airway diseases
Koichiro Asano, Shigeharu Ueki, Mayumi Tamari, et al.
Allergy (2020) Vol. 75, Iss. 12, pp. 3087-3099
Open Access | Times Cited: 82
Dupilumab efficacy in chronic rhinosinusitis with nasal polyps from SINUS‐52 is unaffected by eosinophilic status
Shigeharu Fujieda, Shoji Matsune, Sachio Takeno, et al.
Allergy (2021) Vol. 77, Iss. 1, pp. 186-196
Open Access | Times Cited: 74
Olfactory Outcomes With Dupilumab in Chronic Rhinosinusitis With Nasal Polyps
Joaquim Mullol, Claus Bachert, Nikhil Amin, et al.
The Journal of Allergy and Clinical Immunology In Practice (2021) Vol. 10, Iss. 4, pp. 1086-1095.e5
Open Access | Times Cited: 74
Efficacy and safety of dupilumab in patients with uncontrolled severe chronic rhinosinusitis with nasal polyps and a clinical diagnosis of NSAID‐ERD: Results from two randomized placebo‐controlled phase 3 trials
Joaquim Mullol, Tanya M. Laidlaw, Claus Bachert, et al.
Allergy (2021) Vol. 77, Iss. 4, pp. 1231-1244
Open Access | Times Cited: 71
Effectiveness of Dupilumab in the Treatment of Patients with Severe Uncontrolled CRSwNP: A “Real-Life” Observational Study in the First Year of Treatment
Eugenio De Corso, Stefano Settimi, Claudio Montuori, et al.
Journal of Clinical Medicine (2022) Vol. 11, Iss. 10, pp. 2684-2684
Open Access | Times Cited: 64
Page 1 - Next Page

Scroll to top